Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1066-2019Class II

BVI Visitec Soft Tip Cannula, 0.8MM .50 x 33mm (25G x 1.3 in). The BVI Soft Tip Cannula is intended to...

Becton Dickinson & Co / initiated 2018-11-30 / Terminated / root cause: manufacturing process

Beaver Visitec began a recall of BVI Visitec Soft Tip Cannula, 0.8MM .50 x 33mm (25G x 1.3 in). The BVI Soft Tip Cannula is intended to irrigate and/or aspirate ophthalmic solutions and... on . FDA classified it as Class II and gives the reason as "Certain lots are missing a protective sheath component over the silicone tip, which may result in the silicone tip breaking or detaching at the metal tube component. If the tip becomes detached during a procedure while...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1066-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Becton Dickinson & Co
Product
BVI Visitec Soft Tip Cannula, 0.8MM .50 x 33mm (25G x 1.3 in). The BVI Soft Tip Cannula is intended to irrigate and/or aspirate ophthalmic solutions and liquids in or out of the eye, and remove materials where appropriate (e.g. retinal, subretinal procedures).
Product code
HMX Cannula, Ophthalmic
Reason for recall
Certain lots are missing a protective sheath component over the silicone tip, which may result in the silicone tip breaking or detaching at the metal tube component. If the tip becomes detached during a procedure while in the eye, the fragment will need to be retrieved to mitigate the possibility of injury.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
On 11/30/18, the firm sent an "Urgent: Medical Device Recall" letter dated 11/30/2018 to its customers advising them of the product issue. The letter described the product, problem and actions to be taken. Customers were advised to take the following actions: 1. Immediately examine your inventory and quarantine product from the lots subject to recall. If you may have further distributed this product, please identify your customers and notify them at once of this product recall. Consider all potential users of this product in your user supply chain. You may be supported by including a copy of this recall notification letter. Your assistance is appreciated and necessary to prevent patient harm. 2. Complete and return the enclosed Product Recall Notice Response & Return Form IMMEDIATELY as evidence of the product being returned and we will credit your account OR complete the response form even if you do not have product to return and Fax 866-906-4304 or email a copy to [email protected]. Please include a copy of the completed Response & Return Form with your shipment in Step 3 below. 3. Return ALL quarantined product from the affected lots to our company utilizing the Return Merchandise label that is included with this letter. You may use the prepaid BVI FedEx number for your return. If you have any specific product replacement questions you may contact the Customer Service Team at: [email protected] or call 866-906-8080 from 8:00am to 6:00pm EST (Monday Through Friday). If you have any further questions, contact the Manager, Regulatory Affairs at Phone: 866-906-8080 or 781-906-6925.
Quantity in commerce
3430 units
Distribution
Worldwide distribution: US (nationwide) to states of: AR, AZ, CA, CO, FL, GA, LA, MD, MO, NC, NE, NJ, NY, OH, OK, TX, UT, VA, WA; and countries of: Mexico and Peru.
Product codes and lots
Lots 60047S4, 60060S9, 600623S

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1066-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1066-2019Class IITerminatedVoluntary: Firm initiated